Cargando…
Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
RNA-guided genome surgery using CRISPR-Cas9 nucleases has shown promise for the treatment of diverse genetic diseases. Yet, the potential of such nucleases for therapeutic applications in nongenetic diseases is largely unexplored. Here, we focus on age-related macular degeneration (AMD), a leading c...
Autores principales: | Kim, Kyoungmi, Park, Sung Wook, Kim, Jin Hyoung, Lee, Seung Hwan, Kim, Daesik, Koo, Taeyoung, Kim, Kwang-eun, Kim, Jeong Hun, Kim, Jin-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340969/ https://www.ncbi.nlm.nih.gov/pubmed/28209587 http://dx.doi.org/10.1101/gr.219089.116 |
Ejemplares similares
-
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
por: Koo, Taeyoung, et al.
Publicado: (2018) -
In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
por: Kim, Eunji, et al.
Publicado: (2017) -
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
por: Kim, Sojung, et al.
Publicado: (2014) -
DNA-free two-gene knockout in Chlamydomonas reinhardtii via CRISPR-Cas9 ribonucleoproteins
por: Baek, Kwangryul, et al.
Publicado: (2016) -
Functional Rescue of Dystrophin Deficiency in Mice Caused by Frameshift Mutations Using Campylobacter jejuni Cas9
por: Koo, Taeyoung, et al.
Publicado: (2018)